---
title: "Boston Scientific Corporation Stock 12‑Month Price Target Cut to $83.7, Implies 59% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286824907.md"
description: "Boston Scientific Corporation's average stock price target has been reduced from $85.03 to $83.8, suggesting a potential upside of 59% based on the May 15 closing price. The consensus rating remains 'Buy' among 36 analysts, with 34 Buys and 2 Holds."
datetime: "2026-05-18T22:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286824907.md)
  - [en](https://longbridge.com/en/news/286824907.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286824907.md)
---

# Boston Scientific Corporation Stock 12‑Month Price Target Cut to $83.7, Implies 59% Upside

-   According to estimates from 30 analysts, Boston Scientific Corporation stock's average price target has fallen from $85.03 to $83.8, with forecasts ranging from $60 to $106 per share
-   Based on the May 15 closing price, the updated target implies approximately 59% potential upside
-   Consensus rating remains at “Buy” across 36 covering analysts, with 34 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Boston Scientific Corporation on the , and track all previous and future analyst recommendations for Boston Scientific Corporation in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Boston Scientific enters into $2 billion accelerated share repurchase agreement | BSX Stock News](https://longbridge.com/en/news/286758956.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [BUZZ-Boston Scientific shares rise on $2 bln accelerated buyback](https://longbridge.com/en/news/286801797.md)
- [Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results](https://longbridge.com/en/news/286942821.md)
- [3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22](https://longbridge.com/en/news/286816644.md)